IRON
Price
$69.67
Change
-$1.07 (-1.51%)
Updated
Oct 10, 11:08 AM (EDT)
Capitalization
2.44B
27 days until earnings call
OABI
Price
$1.81
Change
-$0.01 (-0.55%)
Updated
Oct 10, 10:32 AM (EDT)
Capitalization
251.92M
Interact to see
Advertisement

IRON vs OABI

Header iconIRON vs OABI Comparison
Open Charts IRON vs OABIBanner chart's image
Disc Medicine
Price$69.67
Change-$1.07 (-1.51%)
Volume$500
Capitalization2.44B
OmniAb
Price$1.81
Change-$0.01 (-0.55%)
Volume$1.6K
Capitalization251.92M
IRON vs OABI Comparison Chart in %
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRON vs. OABI commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRON is a StrongBuy and OABI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 10, 2025
Stock price -- (IRON: $70.75 vs. OABI: $1.82)
Brand notoriety: IRON and OABI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IRON: 146% vs. OABI: 155%
Market capitalization -- IRON: $2.44B vs. OABI: $251.92M
IRON [@Biotechnology] is valued at $2.44B. OABI’s [@Biotechnology] market capitalization is $251.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRON’s FA Score shows that 0 FA rating(s) are green whileOABI’s FA Score has 1 green FA rating(s).

  • IRON’s FA Score: 0 green, 5 red.
  • OABI’s FA Score: 1 green, 4 red.
According to our system of comparison, IRON is a better buy in the long-term than OABI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRON’s TA Score shows that 4 TA indicator(s) are bullish while OABI’s TA Score has 4 bullish TA indicator(s).

  • IRON’s TA Score: 4 bullish, 4 bearish.
  • OABI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IRON is a better buy in the short-term than OABI.

Price Growth

IRON (@Biotechnology) experienced а +7.42% price change this week, while OABI (@Biotechnology) price change was +13.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.92%. For the same industry, the average monthly price growth was +18.22%, and the average quarterly price growth was +88.00%.

Reported Earning Dates

IRON is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+6.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRON($2.44B) has a higher market cap than OABI($252M). IRON YTD gains are higher at: 11.593 vs. OABI (-48.588). OABI has higher annual earnings (EBITDA): -51.78M vs. IRON (-142.42M). IRON has more cash in the bank: 650M vs. OABI (41.6M). OABI has less debt than IRON: OABI (21.8M) vs IRON (30.9M). OABI has higher revenues than IRON: OABI (23M) vs IRON (0).
IRONOABIIRON / OABI
Capitalization2.44B252M969%
EBITDA-142.42M-51.78M275%
Gain YTD11.593-48.588-24%
P/E RatioN/AN/A-
Revenue023M-
Total Cash650M41.6M1,563%
Total Debt30.9M21.8M142%
TECHNICAL ANALYSIS
Technical Analysis
IRONOABI
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
51%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
57%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
52%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
59%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
48%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
44%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
66%
Declines
ODDS (%)
Bearish Trend about 1 month ago
81%
Bearish Trend 16 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
54%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GACCX29.64N/A
N/A
Gabelli Global Rising Income and Div C
VQNPX72.41N/A
N/A
Vanguard Growth & Income Inv
CIVAX20.30-0.15
-0.73%
American Funds International Vntg 529-A
HAORX16.39-0.13
-0.79%
Harbor International Core Retirement
SAUMX31.16-0.35
-1.11%
SA US Small Company